Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 101
of 6Next
1:

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland.

Wildenberg ME, van Helden-Meeuwsen CG, Drexhage HA, Versnel MA.

Arthritis Res Ther. 2008;10(3):R69. Epub 2008 Jun 19.

PMID: 18565216 [PubMed - in process]

2:

Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice.

Delaleu N, Jonsson R.

Arthritis Res Ther. 2008;10(4):114. Epub 2008 Jul 31.

PMID: 18710591 [PubMed - in process]

3:

Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.

Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB, Humphreys-Beher MG.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5767-71.

PMID: 9159148 [PubMed - indexed for MEDLINE]

4:

Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.

Yamachika S, Brayer J, Oxford GE, Peck AB, Humphreys-Beher MG.

Clin Exp Rheumatol. 2000 Mar-Apr;18(2):233-40.

PMID: 10812497 [PubMed - indexed for MEDLINE]

5:

Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?

Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP.

Eur J Morphol. 1998 Aug;36 Suppl:247-51.

PMID: 9825931 [PubMed - indexed for MEDLINE]

6:

Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.

Yamachika S, Nanni JM, Nguyen KH, Garces L, Lowry JM, Robinson CP, Brayer J, Oxford GE, da Silveira A, Kerr M, Peck AB, Humphreys-Beher MG.

J Rheumatol. 1998 Dec;25(12):2371-80.

PMID: 9858432 [PubMed - indexed for MEDLINE]

7:

Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?

van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, Versnel MA.

Lab Invest. 2000 Apr;80(4):575-85.

PMID: 10780673 [PubMed - indexed for MEDLINE]

8:

Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse.

Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Moreno C, Drexhage HA, Versnel MA.

J Leukoc Biol. 2008 May;83(5):1194-200. Epub 2008 Feb 19.

PMID: 18285404 [PubMed - indexed for MEDLINE]

9:

P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.

Schrader AM, Camden JM, Weisman GA.

Arch Oral Biol. 2005 Jun;50(6):533-40. Epub 2004 Dec 15.

PMID: 15848146 [PubMed - indexed for MEDLINE]

10:

Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjögren's syndrome: limited role for apoptosis in the development of sialoadenitis.

Van Blokland SC, Van Helden-Meeuwsen CG, Wierenga-Wolf AF, Tielemans D, Drexhage HA, Van De Merwe JP, Homo-Delarche F, Versnel MA.

Lab Invest. 2003 Jan;83(1):3-11.

PMID: 12533681 [PubMed - indexed for MEDLINE]

11:

A novel NOD-derived murine model of primary Sjögren's syndrome.

Robinson CP, Yamachika S, Bounous DI, Brayer J, Jonsson R, Holmdahl R, Peck AB, Humphreys-Beher MG.

Arthritis Rheum. 1998 Jan;41(1):150-6.

PMID: 9433880 [PubMed - indexed for MEDLINE]

12:

Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.

Soyfoo MS, De Vriese C, Debaix H, Martin-Martinez MD, Mathieu C, Devuyst O, Steinfeld SD, Delporte C.

Arthritis Rheum. 2007 Aug;56(8):2566-74. Erratum in: Arthritis Rheum. 2007 Sep;56(9):3172.

PMID: 17665453 [PubMed - indexed for MEDLINE]

14:

Sialoadenitis progression in nonobese diabetic mice and its correlation with expression of apoptosis-associated proteins in salivary glands and serum IgG levels.

Qi G, Hua H, Gao Y, Lin Q, Yu GY.

Chin Med J (Engl). 2007 Aug 20;120(16):1426-31.

PMID: 17825172 [PubMed - indexed for MEDLINE]

15:

NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.

Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ.

Oral Dis. 2006 Nov;12(6):566-72.

PMID: 17054769 [PubMed - indexed for MEDLINE]

16:

Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.

Masago R, Aiba-Masago S, Talal N, Zuluaga FJ, Al-Hashimi I, Moody M, Lau CA, Peck AB, Brayer J, Humphreys-Beher MG, Dang H.

Arthritis Rheum. 2001 Mar;44(3):693-702.

PMID: 11263785 [PubMed - indexed for MEDLINE]

17:

New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.

Humphreys-Beher MG, Peck AB.

Arch Oral Biol. 1999 May;44 Suppl 1:S21-5. Review.

PMID: 10414851 [PubMed - indexed for MEDLINE]

18:

Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys.

Kikuchi Y, Ikee R, Hemmi N, Hyodo N, Saigusa T, Namikoshi T, Yamada M, Suzuki S, Miura S.

Nephron Exp Nephrol. 2004;97(1):e17-25.

PMID: 15153757 [PubMed - indexed for MEDLINE]

19:

Autoantibodies in salivary hypofunction in the NOD mouse.

Esch TR, Taubman MA.

Ann N Y Acad Sci. 1998 Apr 15;842:221-8.

PMID: 9599316 [PubMed - indexed for MEDLINE]

20:

Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.

Chen YM, Lin SL, Chen CW, Chiang WC, Tsai TJ, Hsieh BS.

Kidney Int. 2003 Feb;63(2):474-86.

PMID: 12631113 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 101
of 6Next